piracetam has been researched along with Renal Insufficiency, Chronic in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is a frequently used drug in the therapy of partial onset, myoclonic and generalized tonic-clonic seizures." | 3.80 | A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient. ( Bahte, SK; Hiss, M; Kielstein, JT; Lichtinghagen, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahte, SK | 1 |
| Hiss, M | 1 |
| Lichtinghagen, R | 1 |
| Kielstein, JT | 1 |
1 other study available for piracetam and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.
Topics: Aged; Anticonvulsants; Fatigue; Humans; Levetiracetam; Male; Metabolic Clearance Rate; Peritoneal Di | 2014 |